BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15849474)

  • 1. A calcitonin-secreting tumor of the pancreas.
    Iacobone M
    Dig Surg; 2005; 22(1-2):114. PubMed ID: 15849474
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcitonin-secreting tumor of the pancreas.
    Mullerpatan PM; Joshi SR; Shah RC; Tampi CS; Doctor VM; Jagannath P; Modlin I
    Dig Surg; 2004; 21(4):321-4. PubMed ID: 15375334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcaemia induced by excessive parathyroid hormone secretion in a patient with a neuroendocrine tumour.
    Vacher-Coponat H; Opris A; Denizot A; Dussol B; Berland Y
    Nephrol Dial Transplant; 2005 Dec; 20(12):2832-5. PubMed ID: 16188904
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up.
    Nozières C; Chardon L; Goichot B; Borson-Chazot F; Hervieu V; Chikh K; Lombard-Bohas C; Walter T
    Eur J Endocrinol; 2016 Mar; 174(3):335-41. PubMed ID: 26671974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.
    Rossi RE; Naik K; Navalkissoor S; Imber C; O'Beirne J; Toumpanakis C; Caplin ME
    Tumori; 2014; 100(4):153e-6e. PubMed ID: 25296608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protracted hypocalcaemia following a single dose of denosumab in humoral hypercalcaemia of malignancy due to PTHrP-secreting neuroendocrine tumour.
    Teng J; Abell S; Hicks RJ; Hofman MS; Sachithanandan N; McKelvie P; MacIsaac RJ
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):940-2. PubMed ID: 24890549
    [No Abstract]   [Full Text] [Related]  

  • 7. PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor.
    Van den Eynden GG; Neyret A; Fumey G; Rizk-Rabin M; Vermeulen PB; Bouizar Z; Body JJ; Dirix LY
    Bone; 2007 Apr; 40(4):1166-71. PubMed ID: 17188588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcitonin-secreting neuroendocrine carcinoma of the pancreas with splenic invasion and paraneoplastic hypercalcemia].
    Kaassis M; Duquenne M; Croué A; Ronceray J; Rohmer V; Bigorgne JC
    Presse Med; 2001 Jan; 30(1):24. PubMed ID: 11210583
    [No Abstract]   [Full Text] [Related]  

  • 9. Asymptomatic calcitonin-secreting tumor of the pancreas. A case report.
    Delis S; Bakoyiannis A; Giannakou N; Tsigka A; Avgerinos C; Dervenis C
    JOP; 2006 Jan; 7(1):70-3. PubMed ID: 16407623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic luteinizing hormone secretion and anovulation.
    Hirshberg B; Conn PM; Uwaifo GI; Blauer KL; Clark BD; Nieman LK
    N Engl J Med; 2003 Jan; 348(4):312-7. PubMed ID: 12540644
    [No Abstract]   [Full Text] [Related]  

  • 11. [Main indicators of hormonal status in lung diseases].
    Zyrianov BN; Velichko SA; Kuznetsov VV; Siianov VS
    Med Radiol (Mosk); 1988 Aug; 33(8):31-4. PubMed ID: 2842572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe hypercalcaemia from secretion of parathyroid hormone-related peptide.
    Barakat MT; Ashrafian H; Todd JF; Meeran K; Williams GR
    Lancet Oncol; 2004 Oct; 5(10):633-5. PubMed ID: 15465467
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entity.
    Schneider R; Waldmann J; Swaid Z; Ramaswamy A; Fendrich V; Bartsch DK; Schlosser K
    Pancreas; 2011 Mar; 40(2):213-21. PubMed ID: 21178652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases.
    Milanesi A; Yu R; Wolin EM
    Pancreatology; 2013; 13(3):324-6. PubMed ID: 23719609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACTH-secreting pancreatic neoplasms associated with Cushing syndrome: clinicopathologic study of 11 cases and review of the literature.
    Maragliano R; Vanoli A; Albarello L; Milione M; Basturk O; Klimstra DS; Wachtel A; Uccella S; Vicari E; Milesi M; Davì MV; Scarpa A; Sessa F; Capella C; La Rosa S
    Am J Surg Pathol; 2015 Mar; 39(3):374-82. PubMed ID: 25353285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersecretion of calcitonin in patients with the Verner-Morrison syndrome.
    Oberg K; Lööf L; Boström H; Grimelius L; Fahrenkrug J; Lundqvist G
    Scand J Gastroenterol; 1981; 16(1):135-44. PubMed ID: 6262904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic hormones.
    Blackman MR; Rosen SW; Weintraub BD
    Adv Intern Med; 1978; 23():85-113. PubMed ID: 204172
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypercalcemia as the first finding of late recurrence of a PTHrP neuroendocrine tumor of the pancreas.
    Febrero B; Gómez B; Ruiz-Manzanera JJ; Ros-Madrid I; Rodríguez JM
    Endocrinol Diabetes Nutr (Engl Ed); 2024 Jan; 71(1):31-32. PubMed ID: 38350837
    [No Abstract]   [Full Text] [Related]  

  • 19. Cushing's Syndrome Due to CRH and ACTH Co-secreting Pancreatic Tumor--Presentation of a New Case Focusing on Diagnostic Pitfalls.
    Fountas A; Giotaki Z; Ligkros N; Tsakiridou ED; Tigas S; Saeger W; Tsatsoulis A
    Endocr Pathol; 2015 Sep; 26(3):239-42. PubMed ID: 26202047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrolytic migratory erythema associated with alteration from predominantly gastrin-secreting to predominantly glucagon-secreting pancreatic neuroendocrine tumor.
    Kido-Nakahara M; Nakahara T; Miki M; Igarashi H; Ito T; Furue M
    Eur J Dermatol; 2014; 24(6):702-3. PubMed ID: 25333507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.